S&P 500   4,242.81 (-1.06%)
DOW   33,143.18 (-0.87%)
QQQ   357.52 (-1.04%)
AAPL   172.18 (-0.90%)
MSFT   318.38 (-1.06%)
META   303.87 (-0.96%)
GOOGL   133.15 (-0.76%)
AMZN   126.23 (-2.49%)
TSLA   247.52 (-1.62%)
NVDA   446.65 (-0.26%)
NIO   8.59 (-2.28%)
BABA   84.14 (-2.76%)
AMD   102.23 (-1.01%)
T   14.72 (+0.34%)
F   12.16 (-1.22%)
MU   68.83 (+1.28%)
CGC   0.72 (-2.89%)
GE   108.95 (+0.15%)
DIS   81.21 (-0.56%)
AMC   8.10 (-0.61%)
PFE   33.92 (-0.06%)
PYPL   58.11 (-0.77%)
NFLX   385.92 (+1.47%)
S&P 500   4,242.81 (-1.06%)
DOW   33,143.18 (-0.87%)
QQQ   357.52 (-1.04%)
AAPL   172.18 (-0.90%)
MSFT   318.38 (-1.06%)
META   303.87 (-0.96%)
GOOGL   133.15 (-0.76%)
AMZN   126.23 (-2.49%)
TSLA   247.52 (-1.62%)
NVDA   446.65 (-0.26%)
NIO   8.59 (-2.28%)
BABA   84.14 (-2.76%)
AMD   102.23 (-1.01%)
T   14.72 (+0.34%)
F   12.16 (-1.22%)
MU   68.83 (+1.28%)
CGC   0.72 (-2.89%)
GE   108.95 (+0.15%)
DIS   81.21 (-0.56%)
AMC   8.10 (-0.61%)
PFE   33.92 (-0.06%)
PYPL   58.11 (-0.77%)
NFLX   385.92 (+1.47%)
S&P 500   4,242.81 (-1.06%)
DOW   33,143.18 (-0.87%)
QQQ   357.52 (-1.04%)
AAPL   172.18 (-0.90%)
MSFT   318.38 (-1.06%)
META   303.87 (-0.96%)
GOOGL   133.15 (-0.76%)
AMZN   126.23 (-2.49%)
TSLA   247.52 (-1.62%)
NVDA   446.65 (-0.26%)
NIO   8.59 (-2.28%)
BABA   84.14 (-2.76%)
AMD   102.23 (-1.01%)
T   14.72 (+0.34%)
F   12.16 (-1.22%)
MU   68.83 (+1.28%)
CGC   0.72 (-2.89%)
GE   108.95 (+0.15%)
DIS   81.21 (-0.56%)
AMC   8.10 (-0.61%)
PFE   33.92 (-0.06%)
PYPL   58.11 (-0.77%)
NFLX   385.92 (+1.47%)
S&P 500   4,242.81 (-1.06%)
DOW   33,143.18 (-0.87%)
QQQ   357.52 (-1.04%)
AAPL   172.18 (-0.90%)
MSFT   318.38 (-1.06%)
META   303.87 (-0.96%)
GOOGL   133.15 (-0.76%)
AMZN   126.23 (-2.49%)
TSLA   247.52 (-1.62%)
NVDA   446.65 (-0.26%)
NIO   8.59 (-2.28%)
BABA   84.14 (-2.76%)
AMD   102.23 (-1.01%)
T   14.72 (+0.34%)
F   12.16 (-1.22%)
MU   68.83 (+1.28%)
CGC   0.72 (-2.89%)
GE   108.95 (+0.15%)
DIS   81.21 (-0.56%)
AMC   8.10 (-0.61%)
PFE   33.92 (-0.06%)
PYPL   58.11 (-0.77%)
NFLX   385.92 (+1.47%)
NYSE:MLSS

Milestone Scientific (MLSS) Stock Forecast, Price & News

$0.88
-0.01 (-1.66%)
(As of 10:00 AM ET)
Compare
Today's Range
$0.88
$0.88
50-Day Range
$0.90
$1.31
52-Week Range
$0.41
$1.35
Volume
12,711 shs
Average Volume
91,289 shs
Market Capitalization
$62.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MLSS stock logo

About Milestone Scientific (NYSE:MLSS) Stock

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

MLSS Price History

MLSS Stock News Headlines

Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
LUCY SCIENTIFIC DISCOVERY INC
See More Headlines
Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

MLSS Company Calendar

Last Earnings
8/15/2023
Today
10/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Employees
20
Year Founded
N/A

Profitability

Net Income
$-8,710,000.00
Pretax Margin
-75.47%

Debt

Sales & Book Value

Annual Sales
$8.81 million
Book Value
$0.15 per share

Miscellaneous

Free Float
53,382,000
Market Cap
$62.81 million
Optionable
Optionable
Beta
1.35
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Jan Adriaan Haverhals (Age 61)
    Pres, CEO & Director
    Comp: $624.76k
  • Mr. Leonard A. Osser (Age 76)
    Founder, MD of China Operations & Director
  • Mr. Andy Molnar (Age 61)
    Sr. VP of Global Sales & Bus. Devel. for Dental
  • Keisha Harcum
    Controller













MLSS Stock - Frequently Asked Questions

How have MLSS shares performed in 2023?

Milestone Scientific's stock was trading at $0.48 at the start of the year. Since then, MLSS stock has increased by 83.4% and is now trading at $0.8801.
View the best growth stocks for 2023 here
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSE:MLSS) posted its earnings results on Tuesday, August, 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $2.91 million for the quarter. Milestone Scientific had a negative net margin of 74.96% and a negative trailing twelve-month return on equity of 78.34%.

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "MLSS."

How do I buy shares of Milestone Scientific?

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $0.88.

How much money does Milestone Scientific make?

Milestone Scientific (NYSE:MLSS) has a market capitalization of $62.81 million and generates $8.81 million in revenue each year. The company earns $-8,710,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 425 Eagle Rock Avenue Suite 403, Roseland NJ, 07068. The official website for the company is www.milestonescientific.com. The company can be reached via phone at (973) 535-2717, via email at mlss@crescendo-ir.com, or via fax at 973-535-2829.

This page (NYSE:MLSS) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -